Delivery Order SPE2DB20D1109-SPE2DB22FP68D
Award Date 7/22/22
Potential Completion Date 7/25/22
Potential Value $4.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,797.90 firm fixed-price delivery order is for the supply of IMOGAM RABIES-HT 150 UNIT/ML 2ML, a rabies medication. The contract has an ultimate completion date of August 3, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
- This federal contract award, with ID SPE2DB20D1109|SPE2DB22FP97L, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,452.53 firm fixed-price delivery order is for the supply of IMOGAM RABIES-HT, a 150 unit/ml, 2ml rabies medication. The contract does not have a set-aside designation, indicating it was open to full and open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,685.45 firm fixed-price delivery order is for the supply of IMOGAM RABIES-HT 150 UNIT/ML 2ML, a rabies immunoglobulin product. The contract has an ultimate completion date of February 27, 2023 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award, valued at $1,350.24, was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of IMOGAM RABIES-HT, a 150 unit/ml 2ml pharmaceutical product, with an ultimate completion date of October 28, 2022. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. This award is not associated with a set-aside designation,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,439.02 firm fixed-price delivery order is for the supply of IMOGAM RABIES-HT 150 UNIT/ML 2ML, a specialty pharmaceutical product. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of IMOGAM RABIES-HT 150 UNIT/ML 2ML. The $3,312.80 Firm Fixed Price Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by the parent company, Cencora, Inc., doing business as Amerisourcebergen. This IDC serves as the primary vehicle for Amerisourcebergen to provide a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Imogam Rabies-HT 150 unit/mL 2mL vials. The $4,423.78 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for the company to provide a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,506.80 firm fixed-price delivery order contract is for the supply of GLOBULIN RABIES IMMUN medical products. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,568.75 Firm Fixed Price Delivery Order is for the procurement of IMOVAX RABIES VACCINE VIALS, with a performance period through March 18, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of IMOVAX Rabies Vaccine vials, with a ceiling value of $1,313.57 and a performance period through July 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999 and running through November 2026. The IDC...